Drug Approval | September 30, 2024
USFDA completes inspection at Biocon Biologics’ Insulins facility at Malaysia
The inspection concluded with the issuance of a form 483 with five observations
The inspection concluded with the issuance of a form 483 with five observations
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
Subscribe To Our Newsletter & Stay Updated
